空气污染对 bronchiectasis 患者的医疗利用的影响
Hyun Lee1, Sang Hyuk Kim2, Sun-Kyung Lee1,3
1Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
Frontiers in medicine
|October 27, 2023
概括
暴露于PM10,NO2,SO2和CO等空气污染物增加了支气管切除症患者的医疗保健使用率. 即使是这些污染物的低水平也会对结果产生负面影响,没有确定安全门.
科学领域:
- 环境健康 环境健康
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 空气污染物越来越多地与不利的长期健康结果有关.
- 支气管切除症患者可能特别容易受到环境暴露的影响.
研究的目的:
- 调查常见空气污染物暴露与诊断为支气管切除症的个体的医疗保健利用之间的关联.
- 为了确定空气污染物度低于确定的安全水平是否对支气管切除症患者构成风险.
主要方法:
- 在首尔对1,029名支气管切除症患者的回顾性分析.
- 包括主要的空气污染物:PM10,PM2.5,SO2,CO,O3和NO2.
- 医疗保健利用率定义为门诊访问,急诊室访问或住院治疗;生成的度-反应曲线.
主要成果:
- 在PM10,NO2,SO2,CO度和增加医疗保健利用风险之间发现了显著的相关性.
- 即使污染物水平低于一般人群安全值,也观察到风险升高.
- PM10和NO2呈现了对数式风险增加;SO2和CO呈现了分别的反转U形和缓慢向上曲线. PM2.5和O3没有明显的趋势.
结论:
- 高度的PM10,NO2,SO2和CO与支气管切除症患者更高的医疗利用率有关.
- 在支气管切除症患者群体中,没有确定这些污染物的安全暴露值.
- 低水平的空气污染物暴露可能对支气管切除症患者的健康结果产生负面影响.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
217
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
217
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K